China Capital Investment Group
VC Fund
Shanghai, China
China Capital Investment Group is a VC fund in Shanghai focused on Health Care and Education. Founded in 1995 with approval granted by the State Administration for Industry, the China Capital Investment (Group) Co., Ltd. (‘CCIG’) is registered in Shanghai with a registered capital of CNY300 million.CCIG seeks to optimize its investment structure as well as enhance its economic growth and competitive edge by fully harnessing theopportunities unleashed by changes in the global economic structure and China’s economic transformation. To this end, CCIG focuses on industry investments and capital operations and manages its assets in a professional and investment-centered manner that is at the same time grounded in industry experience.Currently, CCIG involves a number of areas, including mining, healthcare, real estate, cultural tourism, Information Technology, energy, and finance and securities. With a strong asset structure and abundant operational cash flow, CCIG is slated to grow its financial strength, establish more quality investment programs, implement excellent management and tap on a strong pool of professional talents as its assets take more a more international profile.
- Total investments:
- 44
- Last investment:
- Lead investor:
- 32%
Last updated:
For AI agents: llms.txt
Industries China Capital Investment Group invests in
Stages China Capital Investment Group invests in
Countries China Capital Investment Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Angel
- $425k–$485k
- Series A
- $1.4M–$11M
- Series C
- $16M–$145M
Investment Focus
Industry
- Health Care 8 (18%)
- Education 6 (14%)
- E-Commerce 6 (14%)
- Medical 5 (11%)
- Biotechnology 4 (9%)
Stage
- Angel 10 (23%)
- Series C 9 (20%)
- Series A 7 (16%)
- Series B 7 (16%)
- Series D 4 (9%)
Country
- China 39 (89%)
- Thailand 1 (2%)
- Hong Kong 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Wei Yan
Macro-economy & Industry Senior Research Manager
|
Macro-economy & Industry Senior Research Manager | Total investments: 0 | Find email | |
Yifei Shao
Senior Investment Manager
|
Senior Investment Manager | Total investments: 0 | Find email | |
|
Yijian Zhou
Executive Director
|
Executive Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
FlashSo Technology
|
FlashSo Technology focuses on the commercialization of physical AI and embodied intelligence technologies, aiming to extend AI from the digital world to real-world physical scenarios. | $5.2M / Series A / Jun 30, 2026 | |
|
Zhongzhuo Industrial Finance
|
Zhongzhuo Industrial Finance is a technological firm that manufactures bathroom and home furnishing items. | $1.7M / Seed / Jan 15, 2026 | |
|
Huaibei Huajian Technology
|
Huaibei Huajian Technology is a technology company that focuses on research and development of a smart healthcare ecosystem network. | $1.1M / Venture - Series Unknown / Jan 07, 2026 | |
| Inventchip provides power conversion solutions based on SiC power devices, SiC driver IC and SiC power modules. Applications: Wind Inverter, PV Inverter, Industrial Power Supply、 HEV/EV, Motor Drive, Charging Pile and other fields, and many. | Series C / Sep 19, 2025 | ||
| Aerospace Yuxing provides global space infrastructure construction and operation services. | $70.7M / Series C / May 06, 2024 | ||
Kenweiting
|
Kenweiting is a Chinese-style burger chain brand. | $1.4M / Seed / Nov 15, 2023 | |
Lihe Weiwei
|
Lihe Weiwei is a food processing firm that produces and supplies condiments and prefabricated vegetables. | Series D / Jul 20, 2022 | |
| Wuhan Binhui Biotechnology Co., Ltd. was established in 2010. The company is located in the Optics Valley Bio City of Donghu National Independent Innovation Demonstration Zone. The company is committed to providing innovative products and services for the field of oncology integration (including diagnosis and treatment), and developing products andservices that have independent intellectual property rights and can compete with other manufacturers on the international stage. | $83M / Series C / Feb 10, 2021 | ||
| Wuhan Binhui Biotechnology Co., Ltd. was established in 2010. The company is located in the Optics Valley Bio City of Donghu National Independent Innovation Demonstration Zone. The company is committed to providing innovative products and services for the field of oncology integration (including diagnosis and treatment), and developing products andservices that have independent intellectual property rights and can compete with other manufacturers on the international stage. | $92.9M / Series B / Feb 10, 2021 | ||
| Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system. | $30M / Series C / Feb 04, 2021 | ||
| See all 44 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does China Capital Investment Group invest in?
China Capital Investment Group invests primarily in Health Care, Education and E-Commerce startups, most often at Angel and Series C stage. Most of the 44 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is China Capital Investment Group's check size?
China Capital Investment Group typically joins rounds of $425k–$485k at Angel, $1.4M–$11M at Series A and $16M–$145M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds China Capital Investment Group participates in.
How do I contact China Capital Investment Group?
Public channels for China Capital Investment Group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at China Capital Investment Group?
The team at China Capital Investment Group includes Wei Yan (Macro-economy & Industry Senior Research Manager), Yifei Shao (Senior Investment Manager) and Yijian Zhou (Executive Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
